GSK bets on chimp virus with $321 million vaccines buy
By Ben Hirschler LONDON, May 29 (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by ac...
Read More »
By Ben Hirschler LONDON, May 29 (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by ac...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - More evidence that Americans are heeding calls to cut back on sugary drinks appears in ...
Read More »By Kate Kelland LONDON (Reuters) - Psychiatrists are developing a system that can help people with schizophrenia control and sometim...
Read More »By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring ...
Read More »
(Reuters) - Amgen Inc, the world's largest biotechnology company, said it entered into a long-term collaboration with Astellas Pharm...
Read More »
By Keith Coffman DENVER (Reuters) - Governor John Hickenlooper on Tuesday signed into law measures to regulate the recreational use ...
Read More »By Kate Kelland LONDON (Reuters) - Chinese scientists have developed the first vaccine to protect children against a virus called en...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Fourteen kids were treated at one Colorado emergency room for accidentally ingesting ...
Read More »By P.J. Huffstutter Chicago (Reuters) - The sudden and widespread appearance of a swine virus deadly to young pigs - one never befor...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Movie characters smoke less since 1998 regulations that stopped tobacco companies fro...
Read More »